New Study Strengthens Rationale for Spectral’s PMX Therapy by Defining Endotoxic Septic Shock (ESS) as the Highest-Risk Patient GroupTORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today highlighted newly published findings in Critical Care Explorations that define endotoxic septic shock (“ESS”) as a distinct and deadly form of septic shock. The prospective, ...

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –Vancouver, BC & Salem, Oregon, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that it has committed to an indirect strategic investment of US$ 145,000 into Agil ...

MALVERN, Pa., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced the publication of a new article in a peer-reviewed journal Biomolecules, which describes the pharmacokinetic (PK) profile of a new crystal form of buntanetap and compares it to the old form across several studie ...

纳斯达克上市状态更新 - 纳斯达克听证小组批准公司继续上市请求 但需满足两项条件：提交截至2025年3月31日财年的10-K年报和2025年6月30日季度的10-Q季报 以及证明股价符合1美元要求 [1] - 公司正与审计机构合作准备延迟报告 预计在宽限期内完成提交 [2] - 若股价未达标 计划通过股东批准实施普通股反向拆股以实现连续10个交易日股价达标要求 [2] 公司业务定位 - 运营技术驱动平台Beneficient 通过AltAccess在线平台为另类资产持有者提供退出机会和初级资本解决方案 [3] - 核心使命是 democratize 全球另类资产投资市场 服务对象包括中高净值个人、中小型机构以及寻求退出方案的普通合伙人 [3] - AltQuote工具可在数分钟内为客户提供潜在退出选项范围 AltAccess门户则提供安全在线环境探索机会 [3] 监管架构 - 子公司Beneficient Fiduciary Financial LLC持有堪萨斯州技术赋能信托金融机构（TEFFI）法案特许牌照 [4] - 受州银行监理官办公室监管 oversight [4] 联系信息 - 投资者关系联系邮箱investors@beneficient.com 媒体联系通过Darrow IR的Matt Kreps和Michael Wetherington [5]

CINCINNATI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, will host a PECO GROW Update for financial advisors and retail investors on Wednesday, September 24, 2025, at 12:00 p.m. ET. During the webcast, PECO will discuss the business and answer questions from financial advisors and retail investors. Chairman and Chief Executive Offic ...

Dallas, TX, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. announces a strategic acquisition of MSTR True North Inc. (True North) in a de minimis cash transaction. True North is cash flow positive and the transaction synergies are expected to allow enhanced platform expansion without additional cost. This move cements Strive’s position at the forefront of Bitcoin advocacy in the new frontier of Digital Capital and Digital Credit. As part of the acquisition, Strive has appointed True North founder Jeff Walt ...

DPRO AUTONOME MAGIC PAYLOAD Tampa, FL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, announced it will attend the upcoming Countering Explosives Conference hosted by Defence iQ. Together with Autonome Labs, Draganfly will highlight progress on the M.A.G.I.C (Mine and Ground Integrated Clearance) system, integrated on Draganfly’s Heavy Lift UAV, which is de ...

First patient in South Korea dosedMIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor today announced activation of two South Korean clinical trial sites participating in its Phase 1/1b open label study to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of PAS-004, in adult participants with neurofibromatosis t ...

COLORADO SPRINGS, Colo., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) – The Fourmile project in Nevada is cementing its position as one of the century’s greatest gold discoveries, updated studies by 100%-owner Barrick show. Backed by ongoing 2025 evaluation results1 and the 2024 mineral resource, the new preliminary economic assessment (PEA) underscores Fourmile’s rare combination of grade, scale and exploration upside, confirming its potential to become one of the world’s ...

CHICAGO and VANCOUVER, British Columbia, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, announced that its board of directors authorized a $50 million share repurchase program. The repurchase program authorizes, pursuant to a normal course issuer bid, the repurchase of up to 10,364,640 of its subordinate voting shares (“shares”) from time to ...